Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Italy.

Karampampa K, Gustavsson A, Miltenburger C, Teruzzi C, Fattore G.

Mult Scler. 2012 Jun;18(2 Suppl):29-34. doi: 10.1177/1352458512441566c. No abstract available.

PMID:
22623125
2.

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Spain.

Karampampa K, Gustavsson A, Miltenburger C, Mora S, Arbizu T.

Mult Scler. 2012 Jun;18(2 Suppl):35-9. doi: 10.1177/1352458512441566d. No abstract available.

PMID:
22623126
3.

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Germany.

Karampampa K, Gustavsson A, Miltenburger C, Neidhardt K, Lang M.

Mult Scler. 2012 Jun;18(2 Suppl):23-7. doi: 10.1177/1352458512441566b. No abstract available.

PMID:
22623124
4.

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France.

Johansson E, Gustavsson A, Miltenburger C, Karampampa K, Rumbach L, Rérat K, Thonnelier C.

Mult Scler. 2012 Jun;18(2 Suppl):17-22. doi: 10.1177/1352458512441566a. No abstract available.

PMID:
22623123
5.

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from the United Kingdom.

Karampampa K, Gustavsson A, Miltenburger C, Tyas D.

Mult Scler. 2012 Jun;18(2 Suppl):41-5. doi: 10.1177/1352458512441566e. No abstract available.

PMID:
22623127
6.

Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.

Karampampa K, Gustavsson A, Miltenburger C, Kindundu CM, Selchen DH.

J Popul Ther Clin Pharmacol. 2012;19(1):e11-25.

PMID:
22247419
7.

The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis.

Fattore G, Lang M, Pugliatti M.

Mult Scler. 2012 Jun;18(2 Suppl):5-6. doi: 10.1177/1352458512447262. No abstract available.

PMID:
22623121
8.

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.

Karampampa K, Gustavsson A, Miltenburger C, Eckert B.

Mult Scler. 2012 Jun;18(2 Suppl):7-15. doi: 10.1177/1352458512441566.

PMID:
22623122
9.

How much is the cost of multiple sclerosis--systematic literature review.

Kolasa K.

Przegl Epidemiol. 2013;67(1):75-9, 157-60. Review. English, Polish.

10.

Impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis.

Dunn J.

Expert Rev Pharmacoecon Outcomes Res. 2010 Aug;10(4):433-40. doi: 10.1586/erp.10.34. Review.

PMID:
20482233
11.

Multiple sclerosis in Italy: cost-of-illness study.

Patti F, Amato MP, Trojano M, Solaro C, Pappalardo A, Zipoli V, Portaccio E, Paolicelli D, Paolillo A, Mennini FS, Marcellusi A, Ricci C, Battaglia MA.

Neurol Sci. 2011 Oct;32(5):787-94. doi: 10.1007/s10072-011-0499-2.

PMID:
21409509
12.

The cost of multiple sclerosis in Australia.

Taylor B, McDonald E, Fantino B, Sedal L, MacDonnell R, Pittas F, Groom T, Beresniak A.

J Clin Neurosci. 2007 Jun;14(6):532-9. Erratum in: J Clin Neurosci. 2008 Oct;15(10):1189. Beresniak, Ariel [added].

PMID:
17430777
13.

The direct cost of patients with multiple sclerosis: a survey from Italian MS centres.

P B, M P A, P B, F B, P C, C F, A L, E M, M R, I L S, M Z.

Neurol Sci. 2011 Dec;32(6):1035-41. doi: 10.1007/s10072-011-0578-4.

PMID:
21505911
14.

Neurologist shortage "critical".

Anderson H, Rydell CM.

Minn Med. 2012 Jan;95(1):6. No abstract available.

PMID:
22355901
15.

The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy.

Amato MP, Battaglia MA, Caputo D, Fattore G, Gerzeli S, Pitaro M, Reggio A, Trojano M; Mu. S. I. C. Study Group..

J Neurol. 2002 Feb;249(2):152-63.

PMID:
11985380
16.

Health status and health care utilization of multiple sclerosis in Canada.

Pohar SL, Jones CA, Warren S, Turpin KV, Warren K.

Can J Neurol Sci. 2007 May;34(2):167-74.

PMID:
17598593
18.

The economic cost of multiple sclerosis in Sweden in 1994.

Henriksson F, Jönsson B.

Pharmacoeconomics. 1998 May;13(5 Pt 2):597-606.

PMID:
17165326
19.
20.

Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.

Rotstein Z, Hazan R, Barak Y, Achiron A.

Autoimmun Rev. 2006 Oct;5(8):511-6. Review.

PMID:
17027884
Items per page

Supplemental Content

Support Center